Profiling Plasma-extracellular Vesicle Proteins and MicroRNAs in Diabetes Onset in Middle-aged Male Participants in the ELSA-Brasil Study

Overview

Journal Physiol Rep

Specialty Physiology

Date 2021 Feb 15

PMID 33587339

Citations 10

Authors

Laureane N Masi

Paulo A Lotufo

Frederico M Ferreira

Alice C Rodrigues

Tamires D A Serdan

Talita Souza-Siqueira

Aecio A Braga

Magda E G Saldarriaga

Tatiana C Alba-Loureiro

Fernanda T Borges

Diego P Cury

Mario H Hirata

Renata Gorjao

Tania C Pithon-Curi

Simao A Lottenberg

Ligia M G Fedeli

Helder T I Nakaya

Isabela J M Bensenor

Rui Curi

Sandro M Hirabara

Affiliations

Soon will be listed here.

Abstract

We measured plasma-derived extracellular vesicle (EV) proteins and their microRNA (miRNA) cargos in normoglycemic (NG), glucose intolerant (GI), and newly diagnosed diabetes mellitus (DM) in middle-aged male participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil). Mass spectrometry revealed decreased IGHG-1 and increased ITIH2 protein levels in the GI group compared with that in the NG group and higher serotransferrin in EVs in the DM group than in those in the NG and GI groups. The GI group also showed increased serum ferritin levels, as evaluated by biochemical analysis, compared with those in both groups. Seventeen miRNAs were differentially expressed (DEMiRs) in the plasma EVs of the three groups. DM patients showed upregulation of miR-141-3p and downregulation of miR-324-5p and -376c-3p compared with the NG and GI groups. The DM and GI groups showed increased miR-26b-5p expression compared with that in the NG group. The DM group showed decreased miR-374b-5p levels compared with those in the GI group and higher concentrations than those in the NG group. Thus, three EV proteins and five DEMiR cargos have potential prognostic importance for diabetic complications mainly associated with the immune function and iron status of GI and DM patients.

Citing Articles

Bioinformatics analysis and validation of novel biomarkers and competitive endogenous RNA networks involved in pyroptosis in diabetic nephropathy.

Wu S, Yao L, Zhang W, Chen P, Jiang J, Ma Y Sci Rep. 2025; 15(1):5530.

PMID: 39953123 PMC: 11829041. DOI: 10.1038/s41598-025-87854-3.

Ferroptosis Altered microRNAs Expression in HT-1080 Fibrosarcoma Cells Based on Small RNA Sequencing and Bioinformatics Analysis.

Zhang Q, Wang Q, Ding H, Hu C, Feng J Nutrients. 2024; 16(6).

PMID: 38542784 PMC: 10976119. DOI: 10.3390/nu16060873.

Systematic review and bioinformatics analysis of plasma and serum extracellular vesicles proteome in type 2 diabetes.

Arredondo-Damian J, Martinez-Soto J, Molina-Pelayo F, Soto-Guzman J, Castro-Sanchez L, Lopez-Soto L Heliyon. 2024; 10(3):e25537.

PMID: 38356516 PMC: 10865249. DOI: 10.1016/j.heliyon.2024.e25537.

Increased small extracellular vesicle levels and decreased miR-126 levels associated with atrial fibrillation and coexisting diabetes mellitus.

Siwaponanan P, Kaewkumdee P, Sudcharee P, Udompunturak S, Chomanee N, Udol K Clin Cardiol. 2023; 46(11):1326-1336.

PMID: 37503820 PMC: 10642338. DOI: 10.1002/clc.24115.

Diagnostic and Therapeutic Roles of Extracellular Vesicles in Aging-Related Diseases.

Sun Z, Hou X, Zhang J, Li J, Wu P, Yan L Oxid Med Cell Longev. 2022; 2022:6742792.

PMID: 35979398 PMC: 9377967. DOI: 10.1155/2022/6742792.

References

Ji J, Qin Y, Ren J, Lu C, Wang R, Dai X . Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN. Sci Rep. 2015; 5:16262. PMC: 4637860. DOI: 10.1038/srep16262. View

Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

Fedeli L, Vidigal P, Leite C, Castilhos C, Pimentel R, Maniero V . [Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil]. Rev Saude Publica. 2013; 47 Suppl 2:63-71. DOI: 10.1590/s0034-8910.2013047003807. View

Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G . Prevalence of body iron excess in the metabolic syndrome. Diabetes Care. 2005; 28(8):2061-3. DOI: 10.2337/diacare.28.8.2061. View

Chen L, Li Y, Zhang F, Zhang S, Zhou X, Ji L . Association of serum ferritin levels with metabolic syndrome and insulin resistance in a Chinese population. J Diabetes Complications. 2016; 31(2):364-368. DOI: 10.1016/j.jdiacomp.2016.06.018. View

Choi D, Kim D, Kim Y, Gho Y . Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. Proteomics. 2013; 13(10-11):1554-71. DOI: 10.1002/pmic.201200329. View

Jin J, Min H, Kim S, Oh S, Kim K, Yu H . Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics. J Diabetes Res. 2015; 2016:6571976. PMC: 4657408. DOI: 10.1155/2016/6571976. View

Karolina D, Armugam A, Tavintharan S, Wong M, Lim S, Sum C . MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011; 6(8):e22839. PMC: 3148231. DOI: 10.1371/journal.pone.0022839. View

Zhang Y, Liu Y, Liu H, Tang W . Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019; 9:19. PMC: 6377728. DOI: 10.1186/s13578-019-0282-2. View

10.

Kim D, Kang B, Kim O, Choi D, Lee J, Kim S . EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles. 2013; 2. PMC: 3760654. DOI: 10.3402/jev.v2i0.20384. View

11.

Nakaya H, Wrammert J, Lee E, Racioppi L, Marie-Kunze S, Nicholas Haining W . Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011; 12(8):786-95. PMC: 3140559. DOI: 10.1038/ni.2067. View

12.

Schmidt M, Hoffmann J, Diniz M, Lotufo P, Griep R, Bensenor I . High prevalence of diabetes and intermediate hyperglycemia - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr. 2015; 6:123. PMC: 4363046. DOI: 10.1186/1758-5996-6-123. View

13.

Jones A, Danielson K, Benton M, Ziegler O, Shah R, Stubbs R . miRNA Signatures of Insulin Resistance in Obesity. Obesity (Silver Spring). 2017; 25(10):1734-1744. PMC: 5614819. DOI: 10.1002/oby.21950. View

14.

Louis C, Desoteux M, Coulouarn C . Exosomal circRNAs: new players in the field of cholangiocarcinoma. Clin Sci (Lond). 2019; 133(21):2239-2244. DOI: 10.1042/CS20190940. View

15.

Teruel-Montoya R, Luengo-Gil G, Vallejo F, Yuste J, Bohdan N, Garcia-Barbera N . Differential miRNA expression profile and proteome in plasma exosomes from patients with paroxysmal nocturnal hemoglobinuria. Sci Rep. 2019; 9(1):3611. PMC: 6401143. DOI: 10.1038/s41598-019-40453-5. View

16.

Lotufo P . [Setting up the longitudinal study for adult health (ELSA-Brasil]. Rev Saude Publica. 2013; 47 Suppl 2:3-9. DOI: 10.1590/s0034-8910.2013047s20002. View

17.

Williams J, Loeffler M . Global Trends in Type 2 Diabetes, 2007-2017. JAMA. 2019; 322(16):1542. DOI: 10.1001/jama.2019.16074. View

18.

Dehwah M, Xu A, Huang Q . MicroRNAs and type 2 diabetes/obesity. J Genet Genomics. 2012; 39(1):11-8. DOI: 10.1016/j.jgg.2011.11.007. View

19.

Schmidt M, Duncan B, Mill J, Lotufo P, Chor D, Barreto S . Cohort Profile: Longitudinal Study of Adult Health (ELSA-Brasil). Int J Epidemiol. 2014; 44(1):68-75. PMC: 4339754. DOI: 10.1093/ije/dyu027. View

20.

Fernandez-Real J, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W . Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes. 2002; 51(4):1000-4. DOI: 10.2337/diabetes.51.4.1000. View